Seizure in Neurodegeneration with Brain Iron Accumulation: A Systematic Review

• Published in: Canadian journal of neurological sciences 2023-01, Vol.50 (1), p.60-71
• Main Authors: Emamikhah, Maziar, Saiyarsarai, Parisa, Schneider, Susanne A., Fasano, Alfonso, Mohammadzadeh, Nahid, Rohani, Mohammad
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Adults; Age; Ataxia; Atrophy; Autism; Brain; Case reports; Child; Child, Preschool; Convulsions & seizures; Dementia; Diabetes; Dystonia; Epilepsy; Fatty acids; Female; Genes; Humans; Intellectual disabilities; Iron; Kinases; Magnetic resonance imaging; Male; Neurodegeneration; Original Article; Pantothenate Kinase-Associated Neurodegeneration; Proteins; Seizures; Spasticity; Systematic review; Young Adult
• ISSN: 0317-1671; 2057-0155
• DOI: 10.1017/cjn.2021.502

Neurodegeneration with brain iron accumulation (NBIA) is a rare genetic disorder. Its clinical manifestations comprise a wide spectrum mainly movement disorders. Seizure as a clinical manifestation is known to occur in some NBIAs, but the exact prevalence of epilepsy in each individual disorder is not well elucidated. The aim of this review was to investigate the frequency of seizures in NBIA disorders as well as to determine the associated features of patients with seizures. The electronic bibliographic databases PubMed, Scopus, Embase, and Google Scholar were systematically searched for all cases in any type of article from inception to December 16, 2019. All the reported cases of NBIA (with or without genetic confirmation) were identified. Case reports with an explicit diagnosis of any types of NBIA, which have reported occurrence (or absence) of any type of seizure or epilepsy, in the English language, were included. Seizure incidence rate, type, and age of onset were reported as frequencies and percentages. 1698 articles were identified and 51 were included in this review. Of 305 reported cases, 150 (49.2%) had seizures (phospholipase A2-associated neurodegeneration (PLAN) = 64 (50.8%), beta-propeller protein-associated neurodegeneration (BPAN) = 57 (72.1%), pantothenate kinase-associated neurodegeneration (PKAN) = 11 (23.4%), and others = 18 (very variable proportions)). The most frequent seizure type in NBIA patients was generalized tonic-clonic seizure with the mean age of seizure onset between 2 and 36 years. However, most of these papers had been published before the new classification of epilepsy became accessible. Affected patients were more likely to be females. Seizures are common in NBIA, particularly in PLAN and BPAN. In PKAN, the most common type of NBIA, around 10% of patients are affected by seizures. BPAN is the most possible NBIA accompanying seizure. Most of the findings regarding the seizure characteristics in the NBIAs are biased due to the huge missing data. Therefore, any conclusions should be made with caution and need further investigations.